COVID-19 Vaccine Market: Nucleic acid vaccines segment to dominate global market

COVID-19 Vaccine Market: Introduction

  • COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate in the host is one of the remarkable properties of this virus. Incubation period for SARS-Cov2 virus is 3-4 days, which is very less as compared to the incubation period of other viruses. This is one of the major cause of its virulence.
  • Mode of transmission for SARS-CoV2 is infected air. A healthy person coming in contact with an infected person through air via sneezing, or respiratory droplets transmission is likely to get infected with the virus. Various approaches are used for the manufacturing of antibodies such as isolation of RNA or DNA of the virus, amplifying them, and conjugating the genetic material with some biomolecules such as lipids that would lead to an elevated immunogenic response of patients.

Read Report Overview -

Key Drivers and Restraints of Global COVID-19 Vaccine Market

  • Continuous and rapid rise in the number of COVID-19 cases among people, its prevalence, and increase in the mortality rate of patients worldwide are key factors driving the market. According to WHO, as of March 06, 2021, globally, there are 114,653,749 confirmed cases of COVID-19, including 2,550,500 deaths reported.
  • Rise in prevalence of diabetes and hypertension also leads to kidney damage. Diabetes is a leading cause of kidney disease. Rise in the number of ongoing clinical trials, increase in funding and drug regulatory approvals from governments, technological advancements, and a large number of corporates investing in the R&D sector are also major factors that are estimated to propel the market.
  • Major challenge to tackle is the relatively small-scale production of COVID-19 vaccine, affordability of price, and improper sales and distribution channel for availability of people when and where needed, especially in local communities needs to be dealt with. These are some factors that may hamper the global COVID-19 market.

Request Brochure of Report -

Nucleic acid vaccines segment to dominate global COVID-19 vaccine market

  • Based on product type, the global COVID-19 vaccine market can be divided into virus vaccine, viral vector vaccines, nucleic acid vaccines, and subunit vaccines. The virus vaccine segment can be further divided into live attenuated and inactivated virus vaccine. The viral vector vaccines segment can be further bifurcated into replicating viral vector, non-replicating viral vector, adenovirus vector vaccines, and lentivirus vector vaccines. The nucleic acid vaccines segment can be further split into mRNA Vaccines and DNA Vaccines.
  • The nucleic acid vaccines segment dominated the global market as mRNA vaccines do not interact with the genetic material of humans, thus having no side-effects and toxicity and absence of virus particle in the vaccine. These are also key factors that are likely to drive the global COVID-19 vaccine market.
  • Ease and large-scale production of the vaccine, its wide availability, and efficacy in treatment of COVID-19 patients are major factors that are estimated to propel the COVID-19 vaccine market

Request for Analysis of COVID-19 Impact on COVID-19 Vaccine Market-

Intramuscular to be lucrative Segment

  • Based on route of administration, the global COVID-19 vaccine market can be divided into intramuscular (IM) and subcutaneous.
  • The intramuscular segment dominated the global market due to increased flexibility. Injections injected intramuscularly act in a better way than injected subcutaneously to patients. These factors together drive the segment.

Hospitals Witness Highest Growth

  • Based on end user, the global COVID-19 vaccine market can be divided into hospitals, COVID-19 clinics, and diagnostic centers
  • The hospitals segment dominated the global COVID-19 vaccine market due to marked percentage (%) increase in number of COVID-19 cases coming to hospitals and clinics day by day and the facilities provided in hospitals such as different screening tests, isolation wards, and other healthcare facilities

Request for Custom Research -

North America to dominate global COVID-19 vaccine market

  • In terms of region, the global COVID-19 vaccine market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America accounts for a prominent share for COVID-19 vaccine market, followed by Europe. Rise in number of COVID-19 cases and their increasing prevalence among patients in North America, technology advancements followed by increased funding from governments in R&D activities and large corporates making huge amount of investments in COVID-19 diagnostics are factors that have led North America to account for a prominent share of the market in the region.

Pre Book COVID-19 Vaccine Market Report -

Key Manufacturers Operating in Market

The global COVID-19 vaccine market was highly fragmented in 2019.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453

Back to news